Visceral Fat Evaluation Using a Dexa Body Composition Scan

Evaluation of Visceral Fat Using a Dexa Body Composition Scan with Attention to Visceral Fat is Very Important. It is a keep predictive of serious metabolic and cardiovascular diseases, and it is actionable, accurate way to determine it, practical, very low radiation, and this is the fat that is hidden inside which is often not detected by providers or patients.  This is the fat that is stored around the vital organs such as the liver, the pancreas, the omentum, and even the coronary arteries.  It is inflammatory, releases hormones, which disrupt metabolism and provoke a lot of inflammation in the body.  Inflammation is related to cardiovascular disease.

Visceral fat is a predictor of risk of heart disease and metabolic disease, even though the patient’s maybe lean.  It is a predictor of diabetes high blood pressure and even certain cancers.

DEXA Body Composition Scan with attention to visceral fat uses very low doses of x-rays of two different energy levels and thereby differentiates tissues such as bone muscle and fat.  Specialists soft with an analyze this data and creates a detailed map of the bodies composition.  The visceral adipose tissue area (VAT) is measured and expressed in sq cm.  An area greater than 100 sq cm is often considered an elevated value and over 160 sq cm is extremely high.  In addition, the android/gynecoid ratio compares abdominal fat to the hip/thigh fat.  A ratio greater than one is associated with increased risk of metabolic diseases as well.

A CT scan evaluation can also evaluate visceral fat.  MRI is the gold standard but it does take a longer time to perform, is more expensive, and not reimbursed by an insurance company.  The most affordable and most accessible route for the evaluation of visceral fat is the DEXA Body Composition Scan with attention to visceral fat

Cardiovascular Disease

AHA Journals: Body Fat Distribution and Risk of Cardiovascular Disease (2012): This review highlights that VAT accumulation, even in individuals who are not obese by BMI standards, is a key driver of the metabolic abnormalities and inflammation that lead to increased CVD risk. The article is available on the American Heart Association Journals site.

European Heart Journal / News-Medical.net: Excessive Visceral Fat Tied to Faster Heart Aging (2025): A study published in the European Heart Journal (and reported in outlets like News-Medical) used AI and imaging data from over 21,000 participants to establish a link between excessive visceral fat and faster aging and stiffening of the heart and blood vessels.

Nutrition, Metabolism and Cardiovascular Diseases: Association between visceral adiposity index and cardiovascular outcomes (2025): This meta-analysis of 17 observational studies involving over 824,000 participants found that a high visceral adiposity index (VAI) was associated with significantly increased risks of CVD, stroke, cardiovascular death, and coronary heart disease (CHD). The study is accessible via ScienceDirect.com or Nutrition, Metabolism and Cardiovascular Diseases.

Circulation Research: Obesity Phenotypes, Diabetes, and Cardiovascular Diseases (2020): This article confirms that cardiometabolic imaging studies have repeatedly shown strong associations between excess visceral adiposity and metabolic abnormalities leading to cardiovascular complications. The full text is available from the American Heart Association Journals. 
Metabolic Disease

Nature: Visceral adiposity is associated with metabolic profiles predictive of type 2 diabetes and myocardial infarction even in normal-weight individuals (2022): This study used MRI to directly measure visceral fat and found it was strongly associated with a metabolic profile (triglyceride-rich lipoproteins, inflammation) that predicts type 2 diabetes and myocardial infarction, even after adjusting for overall BMI or subcutaneous fat. The research is available on Nature.

JACC: Cardiovascular Imaging: Visceral Adiposity and the Risk of Metabolic Syndrome Across Race and Sex (2014): This research demonstrates that higher visceral fat is associated with increased cardiometabolic risk and is a stronger predictor of incident metabolic syndrome than subcutaneous fat, regardless of body weight. The abstract can be accessed on JACC Journals.
Frontiers in Cardiovascular Medicine: Visceral Adipose Tissue and Residual Cardiovascular Risk (2023): This review details how VAT accumulation leads to low-grade systemic inflammation and insulin resistance, playing a major role in developing hypertension and the metabolic syndrome. It is available on Frontiers.

Impact on Longevity

International Journal of Cardiology: Should visceral fat be reduced to increase longevity? (2013): This paper specifically discusses the need to reduce visceral fat as a potential treatment strategy to prevent age-related diseases and increase longevity, citing numerous epidemiological studies that link visceral fat as a major risk factor for death. The article can be found on ScienceDirect.com.
Journal of Gerontology: Medical Sciences / PMC: Fat Distribution and Mortality: The AGES-Reykjavik Study (2016): This large cohort study found that fat distribution is associated with mortality independent of overall fatness, with VAT associated with an increased mortality risk, particularly in obese women. The full text is on the NIH website.

Aging (Albany NY) / PMC: Causal Effect of Visceral Adipose Tissue Accumulation on the Odds of Longevity: A Mendelian Randomization Study (2021): This Mendelian randomization study identified a causal relationship between genetically determined VAT accumulation and lower odds of surviving to the 90th and 99th percentile ages, suggesting a negative causal effect of visceral adiposity on longevity. The full paper is available from the National Institutes of Health (NIH).

Nature Communications: Body fat and risk of all-cause mortality: a systematic review and dose-response meta-analysis (2022): This systematic review and meta-analysis confirmed a positive association between higher VAT area (measured by CT) and an increased risk of all-cause mortality, with a 50 cm² increase linked to a 12% higher risk. It can be accessed on Nature.